¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¾Æ»êº´¿ø Á¦1ȸ ¾Æ»êµÎ°æºÎÆ÷·³ : 2022-07-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¾Æ»êº´¿ø Á¦1ȸ ¾Æ»êµÎ°æºÎÆ÷·³ : 2022-07-23
±³À°ÀÏÀÚ : 2022-07-23
±³À°Àå¼Ò : ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦1ȸ ¾Æ»êµÎ°æºÎÆ÷·³
ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : Ã־ƷÃ
¿¬¶ôó : 02-3010-3710  
À̸ÞÀÏ : ent@amc.seoul.kr      
±³À°Á¾·ù : À̺ñÀÎÈÄ°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ 50,000¿ø, Àü°øÀÇ 30,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 09:00~09:20 Overcoming radioresistance in head and neck cancer  ÇѸí¿ù(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 09:20~09:40 Application of plasma to head and neck disease  ±èöȣ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 09:40~10:00 Treatment strategies through a targeting tumor metabolism  ¹ÚÁ¤Á¦(°æ»óÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 10:00~10:20 Salivary gland cancer: Pathology, genomic alterations and beyond  Á¤ÇѽÅ(¼º±Õ°üÀÇ´ë) 
È޽Ġ07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 10:20~10:40 Coffee Break  () 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 10:40~11:00 Preclinical studies about neural regeneration  ±èÁö¿ø(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 11:00~11:20 Regeneration of larynx and trachea  ±Ç¼º±Ù(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 11:20~11:40 Feedback amplification of senolysis using DEVD-S-DOX and 2DG  ÀÌÁ¾Ã¶(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 11:40~12:00 Updates in experiments about HPV-associated head and neck cancer  Á¤À¯¼®(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 12:00~12:30 My Journey as a doctor preneur  ±è»óÀ±(¿ï»êÀÇ´ë) 
½Ä»ç 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 12:30~13:30 Lunch  () 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 13:30~13:50 Head and neck surgery for novice physician  ±è¹Ì¶ó(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 13:50~14:10 Facial reanimation after treatment of head and neck cancer  Á¤ÀºÀç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 14:10~14:30 Otolaryngologic manifestation and pathologic mechanism of COVID-19  ¹Ú±âö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 14:30~14:50 Implications of sarcopenia and nutrition in head and neck cancer patients  Á¤¾Æ¶ó(À»ÁöÀÇ´ë) 
È޽Ġ07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 14:50~15:10 Coffee Break  () 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 15:10~15:30 Treatment strategy for robust antitumor effect of anti-PD-1 by activating doxorubicin prodrug for head and neck squamous cell carcinoma  ÀÌÀ±¼¼(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 15:30~15:50 Practical tips for designing and performing clinical tirals in oncology  ±è±ÔÇ¥(¿ï»êÀÇ´ë Á¾¾ç³»°ú) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 15:50~16:10 Drug repositioning for treatment of head and neck cancer  ±Ç¹Î¼ö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 16:10~16:30 Various Imaging approach in otolaryngology field: future perspectives  ±èÁرâ(¿ï»êÀÇ´ë À¶ÇÕÀÇÇаú) 
Åä·Ð 07-23 ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç 16:30~16:50 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¾Æ»êº´¿ø Á¦1ȸ ¾Æ»êµÎ°æºÎÆ÷·³ : 2022-07-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÇѸ²´ëÇб³¼º½Éº´¿ø HAUS 2022 (Hands-on training for Arteriovenous access UltraSound) : 2022-07-24
´ÙÀ½±Û (¿ÀÇÁ¶óÀÎ) ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2022-07-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 105 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 6 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 8 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 6 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 3 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 1 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 1 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 1 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20880 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20879 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷